Effectiveness and safety of Everolimus-Exemestane (EVE-EXE) in unselected patients (pts) with HR + /HER2- Metastatic Breast Cancer (MBC): Our experience in clinical practice

Autor:	Rocco Giannicola, M. Raffaele, A. Mafodda, Roberto Maisano, D. Azzarello, P Del Medico, C. Giuffre
Rok vydání:	2016
Předmět:	Oncology medicine.medical_specialty Everolimus business.industry Hematology medicine.disease Metastatic breast cancer Clinical Practice chemistry.chemical_compound Exemestane chemistry Internal medicine medicine business medicine.drug
Zdroj:	Annals of Oncology. 27:iv76
ISSN:	0923-7534
DOI:	10.1093/annonc/mdw337.58
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::5f62b9d9b54d6856a13f254e9a2c2e8a https://doi.org/10.1093/annonc/mdw337.58 Zobrazit plný text záznamu